advanced in vivo models for urological and nephrological research
Our established platform supports the full spectrum of renal and lower urinary tract studies—from acute kidney injury and chronic disease progression to metabolic disorders, autoimmune conditions, and lower urinary tract dysfunctions. With deep expertise in renal physiology, histopathology, and functional analyses, we deliver highly translational models to accelerate your therapeutic development for urinary system diseases.
|
Renal Ischemia-Reperfusion Model |
Induced by temporary clamping of the renal artery (unilateral or bilateral), followed by reperfusion. A standard model for Acute Kidney Injury (AKI) mimicking injury from shock or surgery. |
|
Acute Kidney Injury Model |
A broad category encompassing ischemia-reperfusion, nephrotoxicant, and septic insults. |
|
Nephrotoxicant-Induced AKI Model |
• Cisplatin-Induced AKI: A single injection of the chemotherapeutic agent cisplatin causes acute tubular necrosis, widely used for AKI studies. |
|
Pyelonephritis Model |
Induced by direct instillation of uropathogenic bacteria (e.g., E. coli) into the bladder or kidney, modeling ascending kidney infection. |
|
Unilateral Ureteral Obstruction (UUO) Model |
Induced by surgical ligation of one ureter. The gold-standard model for studying rapid-onset Renal Tubulointerstitial Fibrosis. |
|
Renal Fibrosis Model |
A general term for models like UUO, chronic Angiotensin II infusion, or repeated nephrotoxins, leading to extracellular matrix accumulation. |
|
Cisplatin-Induced Chronic Kidney Disease (CKD) Model |
Established by repeated, low-dose cisplatin injections, leading to sustained tubular injury, inflammation, and fibrosis, modeling CKD post-chemotherapy. |
|
Renal Failure Model (Chronic) |
Represents the end-stage of CKD, often achieved through 5/6 nephrectomy or prolonged UUO, characterized by significantly reduced glomerular filtration rate. |
|
Hypertensive Nephropathy Model |
Induced by chronic infusion of Angiotensin II or using genetic hypertensive strains (e.g., SHR), leading to glomerulosclerosis and proteinuria. |
|
Diabetic Nephropathy Model |
• Streptozotocin (STZ)-Induced Model: STZ injection in mice/rats induces type 1 diabetes, leading to progressive albuminuria and glomerulosclerosis. |
|
Glomerulonephritis Model |
• Anti-GBM Glomerulonephritis: Induced by injection of anti-glomerular basement membrane antibodies. |
|
Hyperuricemia Model |
Induced by potassium oxonate (a uricase inhibitor) in rodents, or by feeding a high-purine diet, leading to elevated serum uric acid. |
|
Nephrolithiasis Model |
Induced by ethylene glycol administration in drinking water, often with ammonium chloride, to promote calcium oxalate crystal formation in the kidneys. |
|
Nephrectomy Model |
• Unilateral Nephrectomy: Surgical removal of one kidney, often as a control or to study compensatory hypertrophy. |
|
Kidney Transplantation Model |
A microsurgical model in rodents (e.g., mouse, rat) for studying allograft rejection, tolerance, and ischemia-reperfusion injury. |
|
Cystitis Model |
• Cyclophosphamide-Induced Cystitis: Intraperitoneal injection of cyclophosphamide causes hemorrhagic cystitis. |
|
Bladder Outlet Obstruction Model |
Induced by partial ligation of the urethra in rodents, modeling benign prostatic hyperplasia (BPH)-related obstruction and subsequent bladder hypertrophy. |
|
Benign Prostatic Hyperplasia (BPH) Model |
Induced in rats by chronic administration of testosterone and estradiol, leading to prostate stromal and epithelial hyperplasia. |
|
Prostatitis Model |
Induced by intraprostatic injection of Complete Freund's Adjuvant (CFA) or by autoimmune induction with prostate tissue homogenates. |
|
Prostate Cancer Model |
• Xenograft: Subcutaneous or orthotopic implantation of human prostate cancer cell lines (e.g., LNCaP, PC-3). |
|
Urethral Injury/Stricture Model |
Created by electrocautery or mechanical scraping of the urethra, leading to fibrosis and stricture formation during healing. |
|
Stress Urinary Incontinence Model |
Induced by vaginal distension or pudendal nerve transection in female rodents, simulating injury during childbirth. |
Global Compliance: AAALAC-accredited facilities with IACUC protocols aligned with EU Directive 2010/63/EU and USDA standards.
Advanced Imaging: DSA, IVUS, angiography, and micro-CT for real-time device performance tracking.
Custom Model Development: Species-specific animal models for complex disease states.
Histopathology Suite: SEM/TEM analysis with GLP-grade reporting for PMDA/CE Mark submissions.